In summary, we have provided evidence that DPP4-expressing fibroblasts are not involved in IPF, and as such DPP4 targeted therapy in IPF is unlikely to have a direct effect on fibroblasts. The gene discussed is DPP4; the disease is idiopathic pulmonary fibrosis.